NCT06751641 Survey of Adult Participants Enrolled in Decentralized Clinical Trials
| NCT ID | NCT06751641 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Nantes University Hospital |
| Condition | Clinical Trial Incorporating Decentralized Elements |
| Study Type | OBSERVATIONAL |
| Enrollment | 200 participants |
| Start Date | 2024-04-05 |
| Primary Completion | 2025-06-05 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 200 participants in total. It began in 2024-04-05 with a primary completion date of 2025-06-05.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Clinical trials (CTs) have become increasingly complex, requiring significant commitment from participants. Decentralized clinical trials (DCTs) offer an alternative by shifting some activities away from traditional sites to locations like the patient's home. This reduces the burden on participants, improves accessibility, and enhances recruitment and retention rates. DCTs leverage digital tools such as telemedicine, electronic consent, and wearable devices for data collection. These methods enable fewer site visits, lowering costs and integrating trials more seamlessly into participants' daily routines. This survey aims to assess the willingness of participants already enrolled in traditional CTs to engage in DCTs. Their prior experience with trial procedures allows them to provide valuable insights into the perceived benefits and feasibility of decentralized elements.
Eligibility Criteria
Inclusion Criteria: Adults. Patients or healthy volunteers, ambulatory, enrolled in an interventional clinical trial evaluating a drug and receiving the trial treatment(s) either at the investigative site and/or at their place of residence. Exclusion Criteria: Individuals who have not expressed their non-opposition to participating in the survey. Individuals participating in a clinical trial with procedures that are not deemed translatable to decentralized procedures.
Contact & Investigator
Laurent Flet, PharmD
PRINCIPAL INVESTIGATOR
Nantes University Hospital
Frequently Asked Questions
Who can join the NCT06751641 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Clinical Trial Incorporating Decentralized Elements. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06751641 currently recruiting?
Yes, NCT06751641 is actively recruiting participants. Contact the research team at laurent.flet@chu-nantes.fr for enrollment information.
Where is the NCT06751641 trial being conducted?
This trial is being conducted at Nantes, France.
Who is sponsoring the NCT06751641 clinical trial?
NCT06751641 is sponsored by Nantes University Hospital. The principal investigator is Laurent Flet, PharmD at Nantes University Hospital. The trial plans to enroll 200 participants.